151 related articles for article (PubMed ID: 36586631)
1. Elaborating the crystal transformation referenced microhydrodynamic model and fracture mechanism combined molecular modelling of irbesartan nanosuspensions formation in wet media milling.
Meng T; Li Y; Ma S; Zhang Q; Qiao F; Hou Y; Gao T; Yang J
Int J Pharm; 2023 Feb; 632():122562. PubMed ID: 36586631
[TBL] [Abstract][Full Text] [Related]
2. Exploring the influence factors and improvement strategies of drug polymorphic transformation combined kinetic and thermodynamic perspectives during the formation of nanosuspensions.
Meng T; Qiao F; Ma S; Gao T; Li L; Hou Y; Yang J
Drug Dev Ind Pharm; 2021 Dec; 47(12):1867-1880. PubMed ID: 35362347
[TBL] [Abstract][Full Text] [Related]
3. A microhydrodynamic rationale for selection of bead size in preparation of drug nanosuspensions via wet stirred media milling.
Li M; Alvarez P; Bilgili E
Int J Pharm; 2017 May; 524(1-2):178-192. PubMed ID: 28380391
[TBL] [Abstract][Full Text] [Related]
4. Impact of process parameters on the breakage kinetics of poorly water-soluble drugs during wet stirred media milling: a microhydrodynamic view.
Afolabi A; Akinlabi O; Bilgili E
Eur J Pharm Sci; 2014 Jan; 51():75-86. PubMed ID: 24036164
[TBL] [Abstract][Full Text] [Related]
5. Review of nanosuspension formulation and process analysis in wet media milling using microhydrodynamic model and emerging characterization methods.
Tian Y; Wang S; Yu Y; Sun W; Fan R; Shi J; Gu W; Wang Z; Zhang H; Zheng A
Int J Pharm; 2022 Jul; 623():121862. PubMed ID: 35671851
[TBL] [Abstract][Full Text] [Related]
6. Impact of media material and process parameters on breakage kinetics-energy consumption during wet media milling of drugs.
Parker N; Rahman M; Bilgili E
Eur J Pharm Biopharm; 2020 Aug; 153():52-67. PubMed ID: 32522681
[TBL] [Abstract][Full Text] [Related]
7. Analysis of heat generation during the production of drug nanosuspensions in a wet stirred media mill.
Guner G; Seetharaman N; Elashri S; Mehaj M; Bilgili E
Int J Pharm; 2022 Aug; 624():122020. PubMed ID: 35842083
[TBL] [Abstract][Full Text] [Related]
8. Continuous production of drug nanoparticle suspensions via wet stirred media milling: a fresh look at the Rehbinder effect.
Monteiro A; Afolabi A; Bilgili E
Drug Dev Ind Pharm; 2013 Feb; 39(2):266-83. PubMed ID: 22503097
[TBL] [Abstract][Full Text] [Related]
9. An Intensified Vibratory Milling Process for Enhancing the Breakage Kinetics during the Preparation of Drug Nanosuspensions.
Li M; Zhang L; Davé RN; Bilgili E
AAPS PharmSciTech; 2016 Apr; 17(2):389-99. PubMed ID: 26182907
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic Modeling of Wet Stirred Media Milling for Production of Drug Nanosuspensions.
Bilgili E; Guner G
AAPS PharmSciTech; 2020 Nov; 22(1):2. PubMed ID: 33222036
[TBL] [Abstract][Full Text] [Related]
11. Exploring space-energy matching via quantum-molecular mechanics modeling and breakage dynamics-energy dissipation via microhydrodynamic modeling to improve the screening efficiency of nanosuspension prepared by wet media milling.
Tian J; Qiao F; Hou Y; Tian B; Yang J
Expert Opin Drug Deliv; 2021 Nov; 18(11):1643-1657. PubMed ID: 34382869
[No Abstract] [Full Text] [Related]
12. Investigation of Formulation and Process Parameters of Wet Media Milling to Develop Etodolac Nanosuspensions.
Karakucuk A; Celebi N
Pharm Res; 2020 May; 37(6):111. PubMed ID: 32476048
[TBL] [Abstract][Full Text] [Related]
13. Development of agomelatine nanocomposite formulations by wet media milling.
Vardaka E; Andreas O; Nikolakakis I; Kachrimanis K
Eur J Pharm Sci; 2021 Nov; 166():105979. PubMed ID: 34425232
[TBL] [Abstract][Full Text] [Related]
14. Use of Bead Mixtures as a Novel Process Optimization Approach to Nanomilling of Drug Suspensions.
Guner G; Kannan M; Berrios M; Bilgili E
Pharm Res; 2021 Jul; 38(7):1279-1296. PubMed ID: 34169438
[TBL] [Abstract][Full Text] [Related]
15. Is roller milling - the low energy wet bead media milling - a reproducible and robust milling method for formulation investigation of aqueous suspensions?
Zulbeari N; Holm R
Int J Pharm; 2024 Feb; 651():123733. PubMed ID: 38142873
[TBL] [Abstract][Full Text] [Related]
16. Development of a Semi-Mechanistic Modeling Framework for Wet Bead Milling of Pharmaceutical Nanosuspensions.
Clancy DJ; Guner G; Chattoraj S; Yao H; Faith MC; Salahshoor Z; Martin KN; Bilgili E
Pharmaceutics; 2024 Mar; 16(3):. PubMed ID: 38543288
[TBL] [Abstract][Full Text] [Related]
17. A quality-by-design study to develop Nifedipine nanosuspension: examining the relative impact of formulation variables, wet media milling process parameters and excipient variability on drug product quality attributes.
Patel PJ; Gajera BY; Dave RH
Drug Dev Ind Pharm; 2018 Dec; 44(12):1942-1952. PubMed ID: 30027778
[TBL] [Abstract][Full Text] [Related]
18. Spatial-thermodynamic understanding of stabilization mechanism using computational approaches and molecular-level elucidation of the mechanism of crystal transformation in polymorphic irbesartan nanosuspensions.
Tian J; Ting Meng T; Ma S; Gao T; Di X; Chen J; Yang J
Int J Pharm; 2022 Jan; 612():121350. PubMed ID: 34896564
[TBL] [Abstract][Full Text] [Related]
19. Formulation and performance of Irbesartan nanocrystalline suspension and granulated or bead-layered dried powders - Part I.
Meruva S; Thool P; Shah S; Karki S; Bowen W; Ghosh I; Kumar S
Int J Pharm; 2019 Sep; 568():118189. PubMed ID: 30851385
[TBL] [Abstract][Full Text] [Related]
20. Do Mixtures of Beads with Different Sizes Improve Wet Stirred Media Milling of Drug Suspensions?
Guner G; Mehaj M; Seetharaman N; Elashri S; Yao HF; Clancy DJ; Bilgili E
Pharmaceutics; 2023 Aug; 15(9):. PubMed ID: 37765182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
